Page 3 - Tobira Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tobira therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tobira Therapeutics Today - Breaking & Trending Today

Zogenix : Amendment to Annual Report (Form 10-K/A)

10-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM
. | March 7, 2022 ....

United States , United Kingdom , Redwood City , Research Triangle Park , North Carolina , San Diego , Syracuse University , District Of Columbia , San Francisco , University Of Southern California , New Jersey , New York , University Of Arizona , Rutgers University , Stanford University , Dana Farber Cancer Institute , South Ayrshire , University Of California San Francisco , Bradleym Galer , Reneep Tannenbaum , Peter Kolchinsky , Ruperth Johnson Jr , Eli Lilly , Bristol Meyers Squibb , Paul Hastings , Los Angeles ,

Syndax Pharmaceuticals Announces Transition of Michael A. Metzger to Chief Executive Officer; Briggs W. Morrison, M.D., to Assume Role of President, Head of Research & Development

/PRNewswire/ Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an. ....

David Rosen , Briggsw Morrison , Regado Biosciences , Melissa Forst , Michaela Metzger , Global Medicines Development , Head Of Research , Company On Twitter , Syndax Pharmaceuticals , Merck Co , University Of Connecticut , York University Stern School Of Business , George Washington University , Georgetown University , Regulatory Affairs At Pfizer , Company Board Of Directors , Clinical Sciences , Exchange Commission , Prnewswire Syndax Pharmaceuticals Inc , Syndax Pharmaceuticals Inc , Chief Operating Officer , Chief Executive Officer , New Drug Application , Tobira Therapeutics , Mersana Therapeutics , Forest Laboratories ,

Investegate |Gain Therapeutics Announcements | Gain Therapeutics: Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors

Gain Therapeutics
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (“Gain”) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Directors. The new board additions will provide strategic guidance as the company focuses on identifying and optimizing allosteric binding sites that have never before been targeted to unlock new treatment options for difficult-to-treat disorders characterized by protein misfolding. In conjunction with the new additions, Dr. Lorenzo Leoni and Dr. Marianne Bjordal will be stepping down from Board. ....

United Kingdom , Bruxelles Capitale , United States , City Of , Khalid Islam , Lorenzo Leoni , Minerva Neurosciences , Bristol Myers Squibb , Gwen Melincoff , Hans Peter Hasler , Marianne Bjordal , Claude Nicaise , Eric Richman , Soleno Therapeutics Inc , Vicuron Pharmaceuticals Inc , Esperion Therapeutics Inc , Department Of Medicine At Columbia , Global Development , Biogen Inc , Eastman Kodak , Collegium Pharmaceutical Inc , Silverstein Foundation For Parkinson , Health Care Administration , George Washington University , Lifesci Communications , Pfizer Inc ,

Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors

(2)
BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. ( Gain ) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Directors. The new board additions will provide strategic guidance as the company focuses on identifying and optimizing allosteric binding sites that have never before been targeted to unlock new treatment options for difficult-to-treat disorders characterized by protein misfolding. In conjunction with the new additions, Dr. Lorenzo Leoni and Dr. Marianne Bjordal will be stepping down from Board.
We are pleased to welcome such a distinguished group of board members at this pivotal time for Gain, said Eric Richman, Chief Executive Officer at Gain. Their decades of experience across the biopharmaceutical industry will be invaluable as we continue to advance our pipeline and determine how our proprietary Site-Directed Enzyme Enhancement Th ....

United Kingdom , Bruxelles Capitale , United States , City Of , Khalid Islam , Lorenzo Leoni , Minerva Neurosciences , Bristol Myers Squibb , Gwen Melincoff , Hans Peter Hasler , Kostenloser Wertpapierhandel , Marianne Bjordal , Claude Nicaise , Eric Richman , Soleno Therapeutics Inc , Vicuron Pharmaceuticals Inc , Esperion Therapeutics Inc , Department Of Medicine At Columbia , Global Development , Biogen Inc , Eastman Kodak , Collegium Pharmaceutical Inc , Health Care Administration , George Washington University , Lifesci Communications , Pfizer Inc ,

Montreux Promotes Jessica Hou to Managing Director

Montreux Promotes Jessica Hou to Managing Director
Share Article
Montreux Growth Partners, a healthcare growth capital firm, announces the appointment of Jessica Hou as Managing Director
SAN FRANCISCO (PRWEB)
December 15, 2020
Montreux Growth Partners, a healthcare growth capital firm, today announced the appointment of Jessica Hou as Managing Director. In this role, she will expand on her leadership in sourcing and leading growth-stage investments in the healthcare sector and in managing the broader Montreux portfolio.
Montreux is excited about this milestone as it looks towards raising its next healthcare growth capital fund with a focus on healthcare technology companies. 2020 has been a productive year for the firm. Recently, Montreux portfolio company Pulmonx priced an upsized IPO and has reached over $1.5 billion in market value. In November, Montreux announced its latest growth capita ....

Danielk Turner , Stanford Graduate School Of Business , Stanford University , Growth Partners , Jessica Hou , Crown Laboratories , Tobira Therapeutics , Managing Director , Quaker Partners , Navigant Consulting , Stanford Graduate School , Human Biology , Montreux Growth Partners , Vista Equity Partners , ஸ்டான்போர்ட் பட்டதாரி பள்ளி ஆஃப் வணிக , ஸ்டான்போர்ட் பல்கலைக்கழகம் , வளர்ச்சி கூட்டாளர்கள் , ஜெசிகா ஹூ , கிரீடம் ஆய்வகங்கள் , நிர்வகித்தல் இயக்குனர் , குவாக்கர் கூட்டாளர்கள் , நேவிகன்ட் ஆலோசனை , ஸ்டான்போர்ட் பட்டதாரி பள்ளி , மனிதன் உயிரியல் , மட்ரூ வளர்ச்சி கூட்டாளர்கள் , விஸ்டா பங்கு கூட்டாளர்கள் ,